Overall survival (OS) in metastatic renal cell carcinoma (mRCC) sequentially treated with different targeted therapies (TTs): Results from a large cohort of patients

被引：0
|
作者：
Procopio, Giuseppe
Verzoni, Elena
Iacovelli, Roberto
Testa, Isabella
Salvioni, Roberto
Nicolai, Nicola
Porcu, Luca
De Braud, Filippo G.
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Univ Roma La Sapienza, Oncol Unit, Dept Radiol Oncol & Human Pathol, Rome, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] Mario Negri Inst Pharmacol Res, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4629
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) SEQUENTIALLY TREATED WITH DIFFERENT TARGETED THERAPIES (TTS): RESULTS FROM A LARGE COHORT OF PATIENTS
    Procopio, G.
    Verzoni, E.
    Testa, I.
    Iacovelli, R.
    Garanzini, E.
    De Braud, F. G. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 272 - 273
  • [2] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS' SEQUENTIALLY TREATED WITH TARGETED THERAPIES (TTS)
    Procopio, G.
    Verzoni, E.
    Testa, I.
    de Braud, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [3] Progression free survival (PFS) and overall survival (OS) in patients receiving 3 targeted therapies (TTs) for metastatic renal-cell carcinoma (mRCC)
    Elena, V.
    Iacovelli, R.
    Santoni, M.
    Di Lorenzo, G.
    Cerbone, L.
    Ortega, C.
    Masini, C.
    Giganti, M. O.
    Messina, C.
    De Vincenzo, F.
    Procopio, G.
    BJU INTERNATIONAL, 2012, 110 : 5 - 5
  • [4] PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS RECEIVING 3 TARGETED THERAPIES (TTS) FOR METASTATIC RENAL-CELL CARCINOMA (MRCC)
    Iacovelli, R.
    Santoni, M.
    Di Lorenzo, G.
    Cerbone, L.
    Aglietta, M.
    Masini, C.
    Giganti, M. O.
    Messina, C.
    Sternberg, C. N.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 270 - 271
  • [5] Progression-free survival (PFS) and overall survival (OS) in patients receiving three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)
    Verzoni, Elena
    Iacovelli, Roberto
    Rizzo, Mimma
    Felici, Alessandra
    Cascinu, Stefano
    Di Lorenzo, Giuseppe
    Cerbone, Linda
    Ortega, Cinzia
    Masini, Cristina
    Giganti, Maria Olga
    Lorusso, Vito
    Messina, Caterina
    Atzori, Francesco
    De Vincenzo, Fabio
    Sacco, Cosimo
    Boccardo, Francesco
    Valduga, Francesco
    Massari, Francesco
    Tassi, Renato
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Prognostic factors for survival in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic therapies: Overall results of a large experience.
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Mattana, F.
    Guadalupi, V.
    Mariani, L.
    Stagni, S.
    Salvioni, R.
    Buzzoni, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience
    Procopio, Giuseppe
    Verzoni, Elena
    Iacovelli, Roberto
    Guadalupi, Valentina
    Gelsomino, Francesco
    Buzzoni, Roberto
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1631 - 1640
  • [8] Time from nephrectomy (Nx) as an independent prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with targeted therapies (TTs)
    Procopio, Giuseppe
    Iacovelli, Roberto
    Verzoni, Elena
    Grassi, Paolo
    Testa, Isabella
    Garanzini, Enrico
    Nicolai, Nicola
    De Braud, Filippo G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [9] Prognostic factors and validation of prognostic nomograms in patients (pts) treated with three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC): Results from an Italian survey
    Iacovelli, Roberto
    Milella, Michele
    Santoni, Matteo
    Di Lorenzo, Giuseppe
    Ortega, Cinzia
    Sabbatini, Roberto
    Ricotta, Riccardo
    Lorusso, Vito
    Messina, Caterina
    Atzori, Francesco
    Zucali, Paolo A.
    Cinieri, Saverio
    Mosca, Alessandra
    Verzoni, Elena
    Primi, Francesca
    Baratelli, Chiara
    Cortesi, Enrico
    Carteni, Giacomo
    Sternberg, Cora N.
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] PROGNOSTIC FACTORS AND VALIDATION OF PROGNOSTIC NOMOGRAMS IN PATIENTS (PTS) TREATED WITH 3 TARGETED THERAPIES (TTS) FOR METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM AN ITALIAN SURVEY
    Iacovelli, R.
    Rizzo, M.
    Lorusso, V.
    Atzori, F.
    Zucali, P. A.
    Sacco, C.
    Boccardo, F.
    Valduga, F.
    Massari, F.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 276 - 277
12345